AzTrials
AzTrials

Premature Baby 26 to 32 WeeksNCT03490721

Effects of Clustering Care on the Physiological Stability of Preterm Infants.

A study testing Clustering care in people with Premature Baby 26 to 32 Weeks, run by Université de Montréal at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This crossover design experimental study aims to compare the physiological stability of premature newborns during and after a cluster of care compared to a period when they receive standard non clustered care at the neonatal unit. Read more about this study

Who is it for?
Ages 26 to 32 weeks
Conditions the study is for
Premature Baby 26 to 32 Weeks
What is being tested?
Clustering care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteCanada
Study dates
12 Sep 2018to 30 May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 26 to 32 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • between 26 to 31 6/7 weeks of gestation at birth
  • more than 72 hours of life,
  • receive a respiratory aid such as endotracheal tube, NIPPV (non invasive positive pressures ventilation), CPAP (continuous positive airway pressure) or nasal prongs with oxygen,
  • are fed intravenously (IV) or by central venous catheter (CVC),
  • one of the parents speaks and reads English or French,
  • one of the parents is at least 18 years old to sign the consent.

Who cannot join

  • severely ill (necrotizing enterocolitis, septicemia),
  • under respiratory assistance or on a high frequency mode,
  • having a congenital or cardiac abnormality,
  • requiring surgery,
  • sedatives or opioids,
  • diagnosed with grade II, III or IV intraventricular hemorrhage and / or hydrocephalus,
Show all 9Show fewer
  • have a device for invasive blood pressure,
  • having an oxygen requirement of more than 30% to maintain oxygen saturation within the limits indicated by the NICU (neonatal intensive care unit).
  • one of the parents is at least 18 years old to sign the consent.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Jewish General Hospital

    Montreal, Quebec, H3T1E2

Other trials in Canada

About this study

Official title: Effects of Clustering Care on the Physiological Stability of Preterm Infants in a Neonatal Intensive Care Unit.

This crossover design experimental study aims to compare the physiological stability of premature newborns during and after a cluster of care compared to a period when they receive standard non clustered care at the neonatal unit.

Read the detailed description

The cluster care will take place at the time of feeding of the premature infants. The intervention will start with a calm period of 20 minutes before the start of care (no manipulations will be allowed), the baby will then received the cluster care for 20 minutes and a quiet period of 30 minutes will follow after the cluster care.

Being tested
Clustering care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clustering careOther

    During 20 minutes, preterm infants will receive a cluster care with 2 minutes of hand containment.

Study groups in NCT03490721
Study groupRoleWhat they receive
InterventionExperimentalClustering care for 20 minutes.
Receives: Other: Clustering care
ControlNo interventionStandard care non clustered.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physiological stability (heart rate, respiratory rate and oxygen saturation)

    The physiological stability will be measured with the SCRIP score. The Stability of the cardiorespiratory system in premature infants is a scale, in which a score of 0 means major physiological instability and a score of 6 means a physiological stability. For every single parameter there's three grades from severe instability (0 points) to minor instability (1 point) to perfect stability (2 points).

    Measured: The physiological stability will be measured for 70 minutes.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2018
  2. Study start12 Sep 2018
  3. Primary completion3 Apr 2019
  4. Study completion30 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03490721
Sponsor's protocol ID
Etude_maitrise_2018
Status last verified
Jan 2020
First submitted
23 Mar 2018
Last updated
18 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The results of this project could be made public in a journal or scientific congress.

Questions about this trial

What is this clinical trial studying?

A study testing Clustering care in people with Premature Baby 26 to 32 Weeks, run by Université de Montréal at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physiological stability (heart rate, respiratory rate and oxygen saturation) (time frame: The physiological stability will be measured for 70 minutes.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in